JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

Axon Medchem

All

Home
Products
- Shop By Category
- Featured Products
- Shop By Alphabet
  - A
  - B
  - C
  - D
  - E
  - F
  - G
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z
  - #
Support
- - Customer Support
  - Customer Services
Contact
- About Axon Medchem
- Contact Us

Imatinib mesylate - CGP 57148B | STI 571 | Gleevec

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1394

CAS [220127-57-1]

MF C29H31N7O.CH4O3S
MW 589.71

Purity: 99%
Soluble in DMSO

Imatinib mesylate

Description

Protein kinase inhibitor, targeting Bcr-Abl/c-kit/PDGF-R.

KEYWORDS: Imatinib mesylate | supplier | Bcr-Abl inhibitor | CGP 57148B | STI 571 | Gleevec | CGP57148B | STI571 | CGP-57148B | STI-571 | CAS [220127-57-1] | [152459-95-5] | Non Selective (Phosphorylation Substrates) | BCR-ABL | c-KIT | PDGFR | Inhibitor | Enzymes

M Deininger and BJ Druker. Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib. Pharmacol. Rev. 2003, 55, 401-423.

TS May. Gleevec: tailoring to fit. Drug Disc. Today (DDT), 2003, 8 (5), 188-189.

Angiogenesis Cell Signaling & Oncology BCR-ABL PDGFR Oncogene Fusion Proteins c-KIT EC 2.7.10.1

Bcr-Abl, c-KIT and PDGFR kinase inhibitor

Chemical name

4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-phenyl]-benzamide mesylate

Parent CAS No.

[152459-95-5]

Order

Size	Unit Price	Stock
10 mg	€60.00	In Stock
50 mg	€95.00	In Stock

Need more? Bulk Inquiry

Please wait...